PAR4 antagonists (Vanderbilt University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePAR4 antagonists (Vanderbilt University)
Drug Alias NameYD-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-4 antagonists
TargetsProtease-activated receptor-4
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVanderbilt University
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A